hotspot -WSS

hotspot

author：focus 2025-08-08 08:10:17 - browse：4

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Bird flu outbreak in cows is latest avian flu curveball

focus

leisure time

WSS

Cell therapy fails to slow type 1 diabetes, but safety is established

Overprescribed: High cost isn't America's only drug problem

H5N1 bird flu virus started spreading in cows in Texas in December

Cancer researcher Catriona Jamieson is sending tumors into space

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Cell therapy fails to slow type 1 diabetes, but safety is established

hotspot

hotspot

focus

Cancer drug shortages should be causing more outrage

More tobacco lobbyists active in statehouses

Medical records are filled with copy

Cholera vaccine supply gets boost as demand surges globally

Supreme Court strikes down use of affirmative action

Harvard scientists, with Google, unveil the most detailed brain map ever

ChatGPT in medicine: STAT answers readers' burning questions

Young boy dies in trial for Pfizer Duchenne gene therapy

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Close Medicare's dangerous gaps in addiction treatment coverage

knowledge

Medical bills so high, Medicare adding extra digits to claim forms

Key Senate committee drafts bipartisan bill to stem drug shortages

Researchers test human milk's ability to repair gut microbiome

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Overprescribed: High cost isn't America's only drug problem

Bird flu reported in person exposed to presumably infected cattle

hotspot

focus

leisure time

knowledge